Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Drug Company PI Date Sort descending Risk List Available?
Pravastatin Sandoz December 2006
Efavirenz Aurobindo Pharma Limited May 2011
Tamoxifen Citrate Mylan Pharmaceuticals April 2013
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013
Pyrazinamide Macleods Pharmaceuticals Limited May 2014
Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate (Teevir) Mylan Pharmaceuticals September 2014
Isoniazid Macleods Pharmaceuticals Ltd August 2015
Intralipid Fresenius Kabi Limited April 2016
Medroxyprogesterone Acetate (DEPO-PROVERA CI) Pfizer January 2017
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences April 2017
Efavirenz (Stocrin) Merck May 2017
Efavirenz (Sustiva) Bristol-Myers Squibb October 2017 YES
Hydroxychloroquine - New Actavis Pharma November 2017
Isoniazid Teva Pharmaceuticals USA, Inc. March 2018
Rifabutin (Mycobutin) Pfizer April 2018
Rifabutin Greenstone LLC April 2018
Levonorgestrel Northstar Rx April 2018
Lamivudine/Zidovudine (Combivir) GlaxoSmithKline April 2018 YES
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences May 2018 YES
Rifapentine (Priftin) Sanofi-Aventis June 2018 YES